Fig. 4From: Anti-Jo-1 autoantibodies: biomarkers of severity and evolution of the disease in antisynthetase syndromeCorrelation between anti-Jo-1 concentration changes and disease activity evolution (global (A), muscular (B), pulmonary (C), cutaneous (D), articular (E), cardiological (F), gastrointestinal (G), constitutional (H) disease activity) in each patient (n = 29) during the follow-upBack to article page